Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local allogeneic adipose-derived mesenchymal stem cell treatment for left-sided ulcerative colitis
2024-518643-38-00Phase 2Completed
- Sponsor
- Central Denmark Region
- Start
- Jun 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of CSCC_ASC in autoimmune colitis, sponsored by Central Denmark Region. Primary endpoint: Primary: endoscopic improvement at day 14. Started Jun 2023; status: completed.
02
Drugs
CSCC_ASC
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2024-518643-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518643-38-00.